Patents by Inventor Roopa NARASIMHAMURTHY

Roopa NARASIMHAMURTHY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-(4-(2-(7,8-DIMETHYL-[1,2,4]TRIAZOLO[1,5-A] PYRIDIN-6-YL)-3-ISOPROPYL-1H-INDOL-5-YL)PIPERIDIN-1-YL)ACETAMIDE SALT AND CRYSTALLINE FORMS THEREOF
    Publication number: 20260226052
    Abstract: Disclosed are salts of 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide and crystalline forms thereof.
    Type: Application
    Filed: March 31, 2026
    Publication date: August 6, 2026
    Inventors: Prashant Mrityunjaya Sujata Kameshwar, Roopa NARASIMHAMURTHY, Qi Gao, Jennifer NELSON
  • 2-(4-(2-(7,8-DIMETHYL-[1,2,4]TRIAZOLO[1,5-A] PYRIDIN-6-YL)-3-ISOPROPYL-1H-INDOL-5-YL)PIPERIDIN-1-YL)ACETAMIDE SALT AND CRYSTALLINE FORMS THEREOF
    Publication number: 20260224551
    Abstract: Disclosed are salts of 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide and crystalline forms thereof.
    Type: Application
    Filed: March 31, 2026
    Publication date: August 6, 2026
    Inventors: Prashant Mrityunjaya Sujata Kameshwar, Roopa NARASIMHAMURTHY, Qi Gao, Jennifer NELSON
  • 2-(4-(2-(7,8-DIMETHYL-[1,2,4]TRIAZOLO[1,5-A] PYRIDIN-6-YL)-3-ISOPROPYL-1H-INDOL-5-YL)PIPERIDIN-1-YL)ACETAMIDE SALT AND CRYSTALLINE FORMS THEREOF
    Publication number: 20260226053
    Abstract: Disclosed are salts of 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a] pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide and crystalline forms thereof.
    Type: Application
    Filed: March 31, 2026
    Publication date: August 6, 2026
    Inventors: Prashant Mrityunjaya Sujata Kameshwar, Roopa NARASIMHAMURTHY, Qi Gao, Jennifer NELSON
  • ENHANCED PERFORMANCE OF AMORPHOUS SOLID AND SOLUBILIZED FORMULATIONS FOR ACHIEVING THERAPEUTIC PLASMA CONCENTRATIONS
    Publication number: 20260042761
    Abstract: This invention relates to solid amorphous dispersions comprising Compound (I) having the formula and one or more polymers or to solution formulations comprising Compound (I) and one or more co-solvents and surfactants. The formulations exhibit enhanced stability and bioavailability.
    Type: Application
    Filed: July 25, 2025
    Publication date: February 12, 2026
    Inventors: Robert J. GARMISE, Jaquan Kalani LEVONS, Jay Poorna REDDY, Kevin J. STEFANSKI, Vrushali M. WAKNIS, Theresa M. ZIEMBA, Ajay SAXENA, Srikanth Koravady SRIDHAR, Gajendra Singh CHOWAN, Sharmistha PAL, Shabeerali PATTASSERI, Roopa NARASIMHAMURTHY, Narayan Swamy PANDURANGA
  • Enhanced performance of amorphous solid and solubilized formulations for achieving therapeutic plasma concentrations
    Patent number: 12509461
    Abstract: This invention relates to solid amorphous Compound (I) having the formula (I) and to solid amorphous dispersions comprising Compound (I) and one or more polymers or to solution formulations comprising Compound (I) and one or more co-solvents and surfactants. The formulations exhibit enhanced stability and bioavailability. This invention relates to solid amorphous dispersions comprising Compound (I) having the formula (I) and one or more polymers or to solution formulations comprising Compound (I) and one or more co-solvents and surfactants. The formulations exhibit enhanced stability and bioavailability.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: December 30, 2025
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Robert J. Garmise, Jaquan Kalani Levons, Jay Poorna Reddy, Kevin J. Stefanski, Vrushali M. Waknis, Theresa M. Ziemba, Ajay Saxena, Srikanth Koravady Sridhar, Gajendra Singh Chowan, Sharmistha Pal, Shabeerali Pattasseri, Roopa Narasimhamurthy, Narayan Swamy Panduranga
  • ENHANCED PERFORMANCE OF AMORPHOUS SOLID AND SOLUBILIZED FORMULATIONS FOR ACHIEVING THERAPEUTIC PLASMA CONCENTRATIONS
    Publication number: 20220144835
    Abstract: This invention relates to solid amorphous Compound (I) having the formula (I) and to solid amorphous dispersions comprising Compound (I) and one or more polymers or to solution formulations comprising Compound (I) and one or more co-solvents and surfactants. The formulations exhibit enhanced stability and bioavailability. This invention relates to solid amorphous dispersions comprising Compound (I) having the formula (I) and one or more polymers or to solution formulations comprising Compound (I) and one or more co-solvents and surfactants. The formulations exhibit enhanced stability and bioavailability.
    Type: Application
    Filed: April 10, 2020
    Publication date: May 12, 2022
    Inventors: Robert J. GARMISE, Jaquan Kalani LEVONS, Jay Poorna REDDY, Kevin J. STEFANSKI, Vrushali M. WAKNIS, Theresa M. ZIEMBA, Ajay SAXENA, Srikanth Koravady SRIDHAR, Gajendra Singh CHOWAN, Sharmistha PAL, Shabeerali PATTASSERI, Roopa NARASIMHAMURTHY, Narayan Swamy PANDURANGA